Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin-Esomeprazole High Dose Dual Therapy vs Levofloxacin Triple Therapy for H. pylori
NCT06088316Phase 4Unknown
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Feb 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of amoxicillin and esomeprazole in Helicobacter pylori infection (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Efficacy of H. pylori eradication. Status: unknown.
02
Drugs
amoxicillinesomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06088316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06088316.